Curability of cancer by radiotherapy and chemotherapy, including in neuraxial neoplasms

Neurology India

Volumn 57, Issue 1, 2009, Pages 13-19

  Jalali, Rakesh ^a   Munshi, Anusheel ^a   Arora, Brijesh ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Cancer; Chemotherapy; Neuroaxial neoplasms; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

BLOOD CELL COUNT; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CYCLING; CYTOPENIA; DIARRHEA; ENDURANCE SPORT; HAIR LOSS; HEALTH CARE PERSONNEL; HUMAN; INFECTION; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEURAXIAL NEOPLASM; ORGAN PRESERVATION; PAIN; REVIEW; SIDE EFFECT; SKIN REDNESS; TESTIS CANCER; UNSPECIFIED SIDE EFFECT; VOMITING; WEAKNESS;

ADULT; CHILD; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NERVOUS SYSTEM NEOPLASMS; RECURRENCE;

EID: 63449142052     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.48794     Document Type: Review

References (37)

1. Matsuda T, Saika K. Comparison of time trends in testicular cancer incidence (1973-97) in East Asia, Europe and USA, from Cancer Incidence in Five Continents Vols IV-VIII. Jpn J Clin Oncol 2008;38:578-9.
2. Kothari M, Goel A. Integrity, immunity, reactivity, restorativity: Biolessons off brain abscess. Neurol India 2008;56:397-8.
3. Kothari M, Goel A. Anticytotics - Radiopalliation/chemopalliation and neuraxial neoplasms. Neurol India 2008;56:113-5.
4. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50.
5. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca Cancer J Clin 2005;55:74-108.
6. Sankaranarayanan R. Commentary: Cancer incidence among Asian Indians in India and abroad. Int J Epidemiol 2008;37:160-1.
7. Dunne-Daly CF. Principles of radiotherapy and radiobiology. Semin Oncol Nurs 1999;15:250-9.
8. Ota T, Takeshima N, Tabata T, Hasumi K, Takizawa K. Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: Long-term survival, late complications, and incidence of second cancers. Br J Cancer 2007;97:1058-62.
9. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19:4029-36.
10. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensitymodulated radiation therapy (IMRT) reduces small bowel, rectum and bladder doses in patients with cervical cancer receiving pelvic and paraaortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-6.
11. del Regato JA, Trailins AH, Pittman DD. Twenty years follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: Report of a national cooperative study. Int J Radiat Oncol Biol Phys 1993;26:197-201.
12. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): A phase III randomised trial. Lancet 2002;360:103-6.
13. Fossa SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, et al. Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. J Clin Oncol 1999;17:1146-52.
14. Classen J, Souchon R, Hehr T, Bamberg M. Radiotherapy for early stages testicular seminoma: Patterns of care study in Germany. Radiother Oncol 2002;63:179-86.
15. Girinsky T, Ghalibafian M. Radiotherapy of Hodgkin lymphoma: Indications, new fields, and techniques. Semin Radiat Oncol 2007;17:206-22.
16. Nogová L, Reineke T, Brillant C, Sieniawski M, Rudiger T, Josting A, et al. Lymphocyte-predominant and classical Hodgkin's lymphoma: A comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol 2008;26:434-9.
17. Pediatric Cancers International Encyclopedia of Public Health, 2008. p. 28-40.
18. Sonn G, Shortliffe LM. Management of Wilms tumor: Current standard of care. Nat Clin Pract Urol 2008;5:551-60.
19. Ludwig JA. Ewing sarcoma: Historical perspectives, current stateof-the-art and opportunities for targeted therapy in the future. Curr Opin Oncol 2008;20:412-8.
20. Aron BS. Twenty years' experience with radiation therapy of medulloblastoma. AJR Am J Roentgenol 1969;105:37-42.
21. Packer RJ. Progress and challenges in childhood brain tumors. J Neurooncol 2005;75:239-42.
22. Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, et al. Radiation therapy for intracranial germinoma: Results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 1999;17:2585-92.
23. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-31
24. Stupp R, Mason WP, van den Brent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma. N Engl J Med 2005;352:987-96.
25. Tufano RP, Stafford EM. Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am 2008;41:741-55.
26. Hosseini SY. Invasive bladder cancer: The role of bladder preserving therapy. Urol J 2005;2:1-7.
27. Peterson KM, Shao C, McCarter R, MacDonald TJ, Byrne J. An analysis of seer data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr Blood Cancer 2006;47:83-8.
28. Available from: http://seer.cancer.gov.
29. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300 000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-65.
30. Fang FM, Tsai WL, Chen HC, Hsu HC, Hsiung CY, Chien CY, et al. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: Comparisons of four radiotherapy techniques. Cancer 2007;109:313-21.
31. Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensitymodulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and paraaortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-6.
32. Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, et al. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurg 2003;52:1348-56.
33. Jalali R, Goswami S, Sarin R. Neuropsychological status in children and young adults with benign and low-grade brain tumors treated prospectively with focal stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:S14-9.
34. Merchant TE, Mulhern RK, Krasin MJ, Kun LE, Williams T, Li C, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation related CNS effects for pediatric patients with localised ependymoma. J Clin Oncol 2004;22:3156-62.
35. Dutta D, Shah N, Gupta T, Munshi A, Jalali R. Prospective analysis of endocrine function in children with residual/recurrent low-grade brain tumors treated with high-precision stereotactic conformal radiotherapy. J Clin Oncol 2008;26:2049.
36. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-9.
37. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124-9.